0001950047-24-001668.txt : 20240301
0001950047-24-001668.hdr.sgml : 20240301
20240301163226
ACCESSION NUMBER: 0001950047-24-001668
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240301
DATE AS OF CHANGE: 20240301
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nkarta, Inc.
CENTRAL INDEX KEY: 0001787400
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 474515206
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39370
FILM NUMBER: 24710487
BUSINESS ADDRESS:
STREET 1: 1150 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (925) 407-1049
MAIL ADDRESS:
STREET 1: 1150 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Brandenberger Ralph
CENTRAL INDEX KEY: 0001853197
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 102
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
144
1
primary_doc.xml
144
0001853197
XXXXXXXX
LIVE
0001787400
NKARTA INC
001-39370
1150 Veterans Boulevard
South San Francisco
CA
94080
4155824923
RALPH ERIK BRANDENBERGER
Officer
COMMON
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York
NY
10004
8367
101073.36
49072342
03/01/2024
NASDAQ
Common
03/01/2024
Exercise of Stock Options
Issuer
N
6763
03/01/2024
Cash
Common
01/14/2023
Restricted Stock Units
Issuer
N
1604
01/14/2023
N/A
Y
The securities to be sold were acquired upon the exercise of stock options and the vesting of restricted stock units from 1/14/2023 through 1/14/2024.
03/01/2024
09/02/2022
/s/ Ralph Erik Brandenberger